Viemed Healthcare (NASDAQ:VMD) Issues Earnings Results

Viemed Healthcare (NASDAQ:VMD) announced its quarterly earnings results on Wednesday. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02, FiscalAI reports. Viemed Healthcare had a return on equity of 9.95% and a net margin of 5.34%.The firm had revenue of $76.18 million for the quarter, compared to analysts’ expectations of $77.70 million.

Viemed Healthcare Trading Up 1.5%

Shares of Viemed Healthcare stock traded up $0.13 on Wednesday, hitting $9.08. The stock had a trading volume of 211,795 shares, compared to its average volume of 167,689. The company has a quick ratio of 1.01, a current ratio of 1.13 and a debt-to-equity ratio of 0.14. Viemed Healthcare has a one year low of $5.93 and a one year high of $9.20. The stock’s 50-day simple moving average is $7.82 and its two-hundred day simple moving average is $7.18. The stock has a market cap of $345.22 million, a price-to-earnings ratio of 27.52 and a beta of 1.23.

Hedge Funds Weigh In On Viemed Healthcare

A number of hedge funds have recently modified their holdings of the company. Wasatch Advisors LP boosted its holdings in shares of Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock worth $10,683,000 after purchasing an additional 240,346 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Viemed Healthcare by 3.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,447,033 shares of the company’s stock valued at $10,751,000 after buying an additional 49,962 shares during the period. Geode Capital Management LLC raised its stake in Viemed Healthcare by 2.0% in the second quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock worth $5,519,000 after buying an additional 15,353 shares in the last quarter. State Street Corp lifted its holdings in Viemed Healthcare by 1.7% in the fourth quarter. State Street Corp now owns 675,190 shares of the company’s stock worth $5,017,000 after buying an additional 11,385 shares during the period. Finally, Punch & Associates Investment Management Inc. boosted its position in Viemed Healthcare by 9.5% during the 3rd quarter. Punch & Associates Investment Management Inc. now owns 671,360 shares of the company’s stock valued at $4,559,000 after acquiring an additional 58,360 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on VMD. Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Zacks Research raised Viemed Healthcare to a “hold” rating in a research note on Thursday, January 8th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.